These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 25909226)
1. Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model. Jiang J; Wang DD; Yang M; Chen D; Pang L; Guo S; Cai J; Wery JP; Li L; Li HQ; Lin PP Oncotarget; 2015 Jun; 6(17):15639-51. PubMed ID: 25909226 [TBL] [Abstract][Full Text] [Related]
2. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells. Ge F; Zhang H; Wang DD; Li L; Lin PP Oncotarget; 2015 Sep; 6(29):27049-64. PubMed ID: 26267323 [TBL] [Abstract][Full Text] [Related]
3. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance. Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer. Li Y; Zhang X; Ge S; Gao J; Gong J; Lu M; Zhang Q; Cao Y; Wang DD; Lin PP; Shen L Oncotarget; 2014 Aug; 5(16):6594-602. PubMed ID: 25026283 [TBL] [Abstract][Full Text] [Related]
5. Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer. Chen Y; Yuan J; Li Y; Li X; Yang Y; Li J; Li Y; Shen L Hum Cell; 2021 Sep; 34(5):1446-1454. PubMed ID: 34152566 [TBL] [Abstract][Full Text] [Related]
6. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis. Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662 [TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis. Ramirez AB; Bhat R; Sahay D; De Angelis C; Thangavel H; Hedayatpour S; Dobrolecki LE; Nardone A; Giuliano M; Nagi C; Rimawi M; Osborne CK; Lewis MT; Stilwell JL; Kaldjian EP; Schiff R; Trivedi MV BMC Cancer; 2019 Mar; 19(1):220. PubMed ID: 30871481 [TBL] [Abstract][Full Text] [Related]
8. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307 [TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma. Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization. Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900 [TBL] [Abstract][Full Text] [Related]
11. [Establishment of A Patient-derived Xenotransplantation Animal Model for Small Cell Lung Cancer and Drug Resistance Model]. Zhu Y; Huang W; Wu Y; Jia L; Li Y; Chen R; Guo L; Chen Q Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):6-14. PubMed ID: 30674387 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of phenotyping and karyotyping of detecting circulating tumor cells in renal cell carcinoma using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH). Tian D; Zhang M; Zheng G; Zhang Y; Li Y; Lin P; Li H; Jiao W; Niu H Int Urol Nephrol; 2020 Dec; 52(12):2281-2287. PubMed ID: 32748196 [TBL] [Abstract][Full Text] [Related]
14. Integrated EpCAM-independent subtraction enrichment and iFISH strategies to detect and classify disseminated and circulating tumors cells. Lin PP Clin Transl Med; 2015 Dec; 4(1):38. PubMed ID: 26718583 [TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of circulating tumor cells from human gastric cancer patients. Yuan D; Chen L; Li M; Xia H; Zhang Y; Chen T; Xia R; Tang Q; Gao F; Mo X; Liu M; Bi F J Cancer Res Clin Oncol; 2015 Apr; 141(4):647-60. PubMed ID: 25326346 [TBL] [Abstract][Full Text] [Related]
16. High expression of MnSOD promotes survival of circulating breast cancer cells and increases their resistance to doxorubicin. Fu A; Ma S; Wei N; Tan BX; Tan EY; Luo KQ Oncotarget; 2016 Aug; 7(31):50239-50257. PubMed ID: 27384484 [TBL] [Abstract][Full Text] [Related]
17. Dynamics of Circulating Tumor Cells Early After Targeting Therapy to Human Ito A; Nakanishi H; Yoshimura M; Ito S; Sakao Y; Kodera Y; Yatabe Y; Kaneda N Anticancer Res; 2019 Sep; 39(9):4711-4720. PubMed ID: 31519570 [TBL] [Abstract][Full Text] [Related]
18. Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells. Williams ES; Rodriguez-Bravo V; Chippada-Venkata U; De Ia Iglesia-Vicente J; Gong Y; Galsky M; Oh W; Cordon-Cardo C; Domingo-Domenech J J Vis Exp; 2015 Oct; (105):53182. PubMed ID: 26555435 [TBL] [Abstract][Full Text] [Related]
19. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer. Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199 [TBL] [Abstract][Full Text] [Related]
20. [A Rare Case of Extremely High Counts of EpCAM Jiang TT; Li HP; Li YC Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):711-715. PubMed ID: 35871746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]